Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023)
William T. Lowrance(University of Utah), Michael S. Cookson(University of Oklahoma Health Sciences Center), Kristen R. Scarpato(Vanderbilt University Medical Center), David F. Jarrard(University of Wisconsin System), Jessica Griffin(Oregon Health & Science University), Sennett K. Kim(American Urological Association), Robert Dreicer(University of Virginia), Erin Kirkby(American Urological Association), David Buckley(Oregon Health & Science University)
Cited by 304
Related Papers
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k